Table 2:
Patient characteristics by PFPT initiation and completion status
| n=268 | p-value | n=156 | p-value | |||
|---|---|---|---|---|---|---|
| Age, years, median (IQR) | 40.1 (32.2, 60.6) | 44.0 (33.6, 60.2) | 0.211 | 38.2 (32.1, 63.9) | 41.0 (32.4, 58.5) | 0.811 |
| Race, % (n) | <0.01 | 0.092 | ||||
| Non-Hispanic White | 55% (127) | 61% (164) | 63% (46) | 52% (81) | ||
| Hispanic | 11% (25) | 15% (39) | 5% (4) | 13% (21) | ||
| Asian | 19% (43) | 7% (19) | 20% (14) | 19% (29) | ||
| Black | 5% (12) | 5% (14) | 1% (1) | 7% (11) | ||
| Other | 5% (12) | 7% (18) | 8% (6) | 4% (6) | ||
| Unknown | 4% (10) | 5% (14) | 3% (2) | 5% (8) | ||
| Parity | 0.262 | 0.062 | ||||
| 0 | 42% (96) | 35% (95) | 55% (40) | 36% (56) | ||
| 1 | 19% (44) | 19% (52) | 19% (14) | 19% (30) | ||
| 2 | 28% (63) | 31% (82) | 18% (13) | 32% (50) | ||
| 3 | 9% (21) | 9% (24) | 7% (5) | 10% (16) | ||
| ≥4 | 2% (5) | 6% (15) | 1% (1) | 3% (4) | ||
| Pregnant at time of referral, % (n) | 5% (11) | 2% (5) | 0.082 | 8% (6) | 3% (5) | 0.112 |
| Postpartum at time of referral, % (n) | 9% (20) | 5% (14) | 0.12 | 5% (4) | 10% (16) | 0.322 |
| Menopausal status, % (n) | 0.48 | 0.73 | ||||
| Premenopausal | 65% (148) | 62% (165) | 63% (46) | 65% (102) | ||
| Postmenopausal | 35% (81) | 38% (103) | 37% (27) | 35% (54) | ||
| Insurance, % (n) | 0.142 | 0.342 | ||||
| Commercial | 86% (197) | 79% (212) | 90% (66) | 84% (131) | ||
| Medicare | 12% (28) | 19% (50) | 10% (7) | 13% (21) | ||
| Medi-Cal | 2% (4) | 1% (4) | 0% (0) | 3% (4) | ||
| Uninsured | 0% (0) | 0% (1) | -- | -- | ||
| Other | 0% (0) | 0% (1) | -- | -- | ||
| Referring diagnosis, % (n) | ||||||
| Urinary incontinence | 51% (116) | 50% (133) | 0.82 | 40% (29) | 56% (87) | 0.02 |
| Voiding dysfunction | 6% (13) | 3% (8) | 0.14 | 5% (4) | 6% (9) | 0.992 |
| IC/PBS | 5% (12) | 5% (14) | 0.99 | 4% (3) | 6% (9) | 0.772 |
| Pelvic pain | 52% (119) | 45% (120) | 0.11 | 63% (46) | 47% (73) | 0.02 |
| Pelvic organ prolapse | 8% (19) | 9% (23) | 0.91 | 7% (5) | 9% (14) | 0.802 |
| Pelvic floor weakness | 2% (4) | 2% (5) | 0.992 | 0% (0) | 2% (4) | 0.312 |
| Anal incontinence | 5% (12) | 3% (8) | 0.20 | 4% (3) | 6% (9) | 0.762 |
| Defecatory dysfunction | 2% (5) | 2% (5) | 0.992 | 5% (2) | 2% (3) | 0.662 |
| Other | 4% (9) | 1% (3) | 0.072 | 1% (1) | 5% (8) | 0.282 |
| Number of referring diagnoses, % (n) | <0.001 2 | 0.332 | ||||
| 1 | 50% (114) | 70% (187) | 49% (36) | 50% (78) | ||
| 2 | 38% (87) | 24% (64) | 38% (28) | 38% (59) | ||
| 3 | 10% (22) | 5% (14) | 13% (9) | 9% (13) | ||
| 4 | 3% (6) | 1% (3) | 0% (0) | 3% (6) | ||
| Prior PFD treatment, % (n) | 39% (90) | 34% (91) | 0.22 | 37% (27) | 40% (63) | 0.62 |
| Prior physical therapy, % (n) | 41% (95) | 33% (89) | 0.06 | 38% (28) | 43% (67) | 0.51 |
| Prior pelvic floor physical therapy, % (n) | 15% (34) | 8% (22) | 0.02 | 14% (10) | 15% (24) | 0.74 |
| Pre-PFDI-20 score, median (IQR)* | 77.6 (46.9, 114.6) | 79.2 (54.2, 112.5) | 0.741 | 66.7 (46.9, 113.6) | 80.2 (47.9, 114.6) | 0.361 |
| Additional therapy provided at referring visit, % (n) | 53% (121) | 41% (110) | <0.01 | 49% (36) | 54% (85) | 0.47 |
| Second referral for PFPT prior to initiating, % (n) | 0.352 | 0.442 | ||||
| Yes, FPMRS | 2% (4) | 0% (1) | 0% (0) | 3% (4) | ||
| Yes, Non-FPMRS | 4% (9) | 4% (10) | 3% (2) | 4% (7) | ||
| Co-pay per PFPT session, % (n) | 0.382 | |||||
| $0–25 | -- | -- | -- | 79% (58) | 86% (134) | |
| $26–50 | -- | -- | -- | 20% (14) | 13% (20) | |
| ≥$51 | -- | -- | -- | 1% (1) | 1% (2) |
1.
Wilcoxon rank-sum
2.
Fisher’s exact
Abbreviations: IC/PBS=interstitial cystitis/painful bladder syndrome; PFD=pelvic floor disorder; PFDI=Pelvic Floor Distress Inventory; PFPT=pelvic floor physical therapy; FPMRS=Female Pelvic Medicine and Reconstructive Surgery